Modular Medical announced that the first patients have completed onboarding and are now actively using the Pivot tubeless insulin patch pump in real-world settings. The milestone marks the transition from development to active patient use and represents a significant step in the company's commercialization strategy. The company will now collect real-world utilization data and user feedback to support broader adoption and continued product deployment optimization. The Pivot pump recently became commercially available in the U.S. following FDA 510(k) clearance, and is described as the first two-part tubeless patch pump featuring a removable 3 mL reservoir, disposable battery, and smartphone connectivity.
Modular Medical IncFirst active users of Pivot insulin pump mark transition from development to real-world use, a key milestone.